From the RNA-seq analyses of LSD1 inhibitor treated PCa cells, we found that LSD1-activated genes were enriched for PI3K/AKT pathway (14) in absence of androgen stimulation and we further confirmed that LSD1 inhibition significantly decreased AKT phosphorylation independent of DHT treatment. The gene discussed is AKT1; the disease is posterior cortical atrophy.